Somatic Mutations in Breast Cancer Genomes : Discovery and Validation of Breast Cancer Genes
Breast cancer is the most common cancer in women worldwide. However, the genetic alterations that lead to breast cancer are not fully understood. This thesis aims to identify novel genes of potential mechanistic, diagnostic or therapeutic interest in breast cancers by mutational analysis and whole-g...
Main Author: | |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
Uppsala universitet, Institutionen för immunologi, genetik och patologi
2012
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-182319 http://nbn-resolving.de/urn:isbn:978-91-554-8490-3 |
id |
ndltd-UPSALLA1-oai-DiVA.org-uu-182319 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-UPSALLA1-oai-DiVA.org-uu-1823192013-01-23T15:40:49ZSomatic Mutations in Breast Cancer Genomes : Discovery and Validation of Breast Cancer GenesengJiao, XiangUppsala universitet, Institutionen för immunologi, genetik och patologiUppsala2012breast cancercancer genepathwaysomatic mutationstructural alterationsequencingwhole genome amplificationBreast cancer is the most common cancer in women worldwide. However, the genetic alterations that lead to breast cancer are not fully understood. This thesis aims to identify novel genes of potential mechanistic, diagnostic or therapeutic interest in breast cancers by mutational analysis and whole-genome sequencing. In paper I, sequencing of 36 previously identified candidate genes in 96 breast tumors with patient-matched normal DNA determined the somatic mutation prevalence of these candidate genes and identified additional mutations in Notch, NF-κB, PI3K, and Hedgehog pathways as well as in processes mediating DNA methylation, RNA processing and calcium signaling. In paper II, comparison of massively parallel mate-pair sequencing results of a human genome before and after phi29-mediated multiple displacement amplification (MDA) revealed that MDA introduces structural alteration artifacts, with an emphasis on false positive inversions, and impairs the sensitivity to detect true inversions. Therefore, MDA has limited value in sample preparation for whole-genome sequencing for structural alteration detection. In paper III, massively parallel paired-end sequencing identified gene rearrangements in 15 hormone receptor negative breast cancers. Forty validated rearrangements were predicted to directly affect 30 genes, involved in epigenetic regulation, cell mitosis, signalling transduction and glycolytic flux. RNA interference-based assays revealed the potential roles in cell growth of some affected genes, among which DDX10 was implicated to be involved in apoptosis. In paper IV, a method for statistical evaluation of putative translocations detected by massively parallel paired-end sequencing was proposed. In an application of this method to analyse translocations detected by cancer genome deep paired-end sequencing, 76 putative translocations were classified into four categories, with the majority likely to be caused by mismapping due to repetitive regions. Taken together, this thesis provides insights into genes and pathways mutated in sporadic breast cancer genomes, which broaden our understanding of the genetic basis of breast cancer and may ultimately facilitate the diagnosis and treatment of this disease. Doctoral thesis, comprehensive summaryinfo:eu-repo/semantics/doctoralThesistexthttp://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-182319urn:isbn:978-91-554-8490-3Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, 1651-6206 ; 822application/pdfinfo:eu-repo/semantics/openAccess |
collection |
NDLTD |
language |
English |
format |
Doctoral Thesis |
sources |
NDLTD |
topic |
breast cancer cancer gene pathway somatic mutation structural alteration sequencing whole genome amplification |
spellingShingle |
breast cancer cancer gene pathway somatic mutation structural alteration sequencing whole genome amplification Jiao, Xiang Somatic Mutations in Breast Cancer Genomes : Discovery and Validation of Breast Cancer Genes |
description |
Breast cancer is the most common cancer in women worldwide. However, the genetic alterations that lead to breast cancer are not fully understood. This thesis aims to identify novel genes of potential mechanistic, diagnostic or therapeutic interest in breast cancers by mutational analysis and whole-genome sequencing. In paper I, sequencing of 36 previously identified candidate genes in 96 breast tumors with patient-matched normal DNA determined the somatic mutation prevalence of these candidate genes and identified additional mutations in Notch, NF-κB, PI3K, and Hedgehog pathways as well as in processes mediating DNA methylation, RNA processing and calcium signaling. In paper II, comparison of massively parallel mate-pair sequencing results of a human genome before and after phi29-mediated multiple displacement amplification (MDA) revealed that MDA introduces structural alteration artifacts, with an emphasis on false positive inversions, and impairs the sensitivity to detect true inversions. Therefore, MDA has limited value in sample preparation for whole-genome sequencing for structural alteration detection. In paper III, massively parallel paired-end sequencing identified gene rearrangements in 15 hormone receptor negative breast cancers. Forty validated rearrangements were predicted to directly affect 30 genes, involved in epigenetic regulation, cell mitosis, signalling transduction and glycolytic flux. RNA interference-based assays revealed the potential roles in cell growth of some affected genes, among which DDX10 was implicated to be involved in apoptosis. In paper IV, a method for statistical evaluation of putative translocations detected by massively parallel paired-end sequencing was proposed. In an application of this method to analyse translocations detected by cancer genome deep paired-end sequencing, 76 putative translocations were classified into four categories, with the majority likely to be caused by mismapping due to repetitive regions. Taken together, this thesis provides insights into genes and pathways mutated in sporadic breast cancer genomes, which broaden our understanding of the genetic basis of breast cancer and may ultimately facilitate the diagnosis and treatment of this disease. |
author |
Jiao, Xiang |
author_facet |
Jiao, Xiang |
author_sort |
Jiao, Xiang |
title |
Somatic Mutations in Breast Cancer Genomes : Discovery and Validation of Breast Cancer Genes |
title_short |
Somatic Mutations in Breast Cancer Genomes : Discovery and Validation of Breast Cancer Genes |
title_full |
Somatic Mutations in Breast Cancer Genomes : Discovery and Validation of Breast Cancer Genes |
title_fullStr |
Somatic Mutations in Breast Cancer Genomes : Discovery and Validation of Breast Cancer Genes |
title_full_unstemmed |
Somatic Mutations in Breast Cancer Genomes : Discovery and Validation of Breast Cancer Genes |
title_sort |
somatic mutations in breast cancer genomes : discovery and validation of breast cancer genes |
publisher |
Uppsala universitet, Institutionen för immunologi, genetik och patologi |
publishDate |
2012 |
url |
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-182319 http://nbn-resolving.de/urn:isbn:978-91-554-8490-3 |
work_keys_str_mv |
AT jiaoxiang somaticmutationsinbreastcancergenomesdiscoveryandvalidationofbreastcancergenes |
_version_ |
1716575987479609344 |